PTPN1 is a prognostic biomarker related to cancer immunity and drug sensitivity: from pan-cancer analysis to validation in breast cancer

BACKGROUND: Protein tyrosine phosphatase non-receptor type 1 (PTPN1), a member of the protein tyrosine phosphatase superfamily, has been identified as an oncogene and therapeutic target in various cancers. However, its precise role in determining the prognosis of human cancer and immunological respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Ruijun, Chen, Shuanglong, Cui, Weiheng, Xie, Chaoyu, Zhang, Aiping, Yang, Li, Dong, Hongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626546/
https://www.ncbi.nlm.nih.gov/pubmed/37936713
http://dx.doi.org/10.3389/fimmu.2023.1232047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626546/
https://www.ncbi.nlm.nih.gov/pubmed/37936713
http://dx.doi.org/10.3389/fimmu.2023.1232047

Ejemplares similares